语言版本

Time of issue:2021-09-02 16:56:33

中文 English





搜索

Search





Homepage

/

Product

/

API

/

Olopatadine HCl

All categories



Number of views:

1000

Olopatadine HCl

Olopatadine HCl was developed by Kyowa Hakko Kirin, and it was first approved by the FOOD and Drug Administration (FDA) of the United States on December 18, 1996,

Retail price

0.0

元

Market price

0.0

元

Number of views:

1000

No.

Category

API

Chemical Name:

11-(Z)-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenzo[b,e]oxepin-2-acetic acid, hydrochloride

Molecular Formula:

C21H23O3N·HCl

Molecular Weight:

373.88

Therapeutic Classification:

Antihistamine

CAS:

140462-76-6

Registration File:

US-DMF, JDMF, etc.

Quantity

-

+

Stock:



1

Detail

Parameters

　　Olopatadine HCl was developed by Kyowa Hakko Kirin, and it was first approved by the FOOD and Drug Administration (FDA) of the United States on December 18, 1996, and later approved by the Japanese Pharmaceutical and Medical Device Comprehensive Organization (PMDA) on December 22, 2000. It was approved for marketing by the European Medicines Agency (EMA) on 17 May 2002. It is sold in the United States by Alcon with the name Patanol. Olopatadine HCl is an antihistamine (an anticholinergic medicine and mast cell stabilizers), which is suitable for the treatment of allergic conjunctivitis. Patanol is an eye drop containing 0.1% olopatadine. The recommended dose is 1 drop to the affected eye twice a day with an interval of 6-8 hours.

Keyword:

Olopatadine

Patanol

Scan the QR code to read on your phone